Bruno Daniele
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori(IT)Ospedale D. Cotugno(IT)University of Naples Federico II(IT)University of Bologna(IT)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial(2018)2,498 cited
- → Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial(2019)1,782 cited
- → Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial(2019)1,630 cited
- → Radiofrequency Ablation of Unresectable Primary and Metastatic Hepatic Malignancies(1999)1,072 cited
- → Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(2018)1,047 cited
- → Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib